Bekraoui, N, Boussaidi, L, Cazorla, G, and Léger, L. Oxygen uptake, heart rate, and lactate responses for continuous forward running and stop-and-go running with and without directional changes. J Strength Cond Res 34(3): 699-707, 2020-The purpose of this study is to measure and quantify the differences for the gross oxygen uptake (V[Combining Dot Above]O2), heart rate (HR), and blood lactate ([LA]) responses to various modes of in-line running. Twelve healthy participants did an indirect continuous multistage field test to determine the maximal aerobic speed (MAS) before randomly performing in separate sessions 1 of the 3 running protocols at 3 intensities (60, 70, and 80% MAS) (a) in-line continuous running (IR), (b) fractioned running (FR) with stop and go every 20 m, and (c) 20-m shuttle run (SR). V[Combining Dot Above]O2 varied between 34.2 ± 2.5 and 54.6 ± 5.4 ml·kg·min, HR between 141 ± 14 and 184 ± 9 b·min, and [LA] between 4.2 ± 0.8 and 6.6 ± 0.9 mmol·L. In-line continuous running V[Combining Dot Above]O2 was lower than those of SR and FR at all intensities (p < 0.05). However, SR V[Combining Dot Above]O2 were higher than those of FR at 80% MAS only. Heart rate was similar in SR and FR but lower in IR at all intensities (p < 0.05). No significant differences were recorded in [LA]. Because only V[Combining Dot Above]O2 was affected by the introduction of a 180° angle directional change (SR vs. FR) at 80% MAS, the use of HR to assess such activities at such intensities will result in underestimating workloads. This study offers new insights into V[Combining Dot Above]O2, HR, and [LA] associated with accelerations while running with and without directional changes at submaximal speeds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1519/JSC.0000000000002802 | DOI Listing |
Implement Sci Commun
January 2025
Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, IL, Chicago, USA.
Background: Studies have demonstrated that standardizing labor induction (IOL), often with the use of protocols, may reduce racial inequities in obstetrics. IOL protocols are complex, multi-component interventions. To target identified implementation barriers, audit and feedback (A&F) was selected as an implementation strategy.
View Article and Find Full Text PDFMol Cell Biochem
January 2025
Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
Chronic/heavy exposure with ethanol is associated with risk of type 2 diabetes, due to β-cells dysfunction. It has been reported that ethanol can induce oxidative stress directly or indirectly by involvement of mitochondria. We aimed to explore the protective effects of the crocin/gallic acid/L-alliin as natural antioxidants separately on ethanol-induced mitochondrial damage.
View Article and Find Full Text PDFNeurol Ther
January 2025
Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a genetic disorder characterized by the deposition of misfolded transthyretin (TTR) protein in tissues, resulting in progressive dysfunction of multiple organs, including the nervous system, heart, kidneys, and gastrointestinal (GI) tract. Noninvasive serum biomarkers have become key tools for diagnosing and monitoring ATTRv. This review examines the role of available biomarkers for neurological, cardiac, renal, gastrointestinal, and multisystemic involvement in ATTRv.
View Article and Find Full Text PDFNat Med
January 2025
BioNTech US, Cambridge, MA, USA.
New treatment approaches are warranted for patients with advanced melanoma refractory to immune checkpoint blockade (ICB) or BRAF-targeted therapy. We designed BNT221, a personalized, neoantigen-specific autologous T cell product derived from peripheral blood, and tested this in a 3 + 3 dose-finding study with two dose levels (DLs) in patients with locally advanced or metastatic melanoma, disease progression after ICB, measurable disease (Response Evaluation Criteria in Solid Tumors version 1.1) and, where appropriate, BRAF-targeted therapy.
View Article and Find Full Text PDFNat Med
January 2025
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Nearly all pancreatic adenocarcinomas (PDAC) are genomically characterized by KRAS exon 2 mutations. Most patients with PDAC present with advanced disease and are treated with cytotoxic therapy. Genomic biomarkers prognostic of disease outcomes have been challenging to identify.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!